Cyanamide

Cyanamide

SCHEMBL415829

N#CN.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Cyanamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyanamide SCHEMBL28252461 1.00
Cyanamide SCHEMBL8859746 1.00
Cyanamide SCHEMBL1972 1.00
Cyanamide SCHEMBL30536975 1.00
Cyanamide SCHEMBL23040979 0.93
Cyanamide SCHEMBL141578 0.93
Cyanamide SCHEMBL8189110 0.93
Cyanamide SCHEMBL5696325 0.93
Cyanamide SCHEMBL1274151 0.93
Cyanamide SCHEMBL5696286 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-213007412-U High-strength tire 青岛力富金属制造有限公司 2021-04-20 CN disclosed
CN-110190256-A A kind of antimony oxide/nitrogen-doped graphene composite material and preparation method and application 广东工业大学 2019-08-30 CN disclosed
CN-208638199-U Motor shell with externally-embedded heat dissipation device 东莞市汇大明智能科技有限公司 2019-03-22 CN disclosed
CN-208395094-U Conductive adhesive with waterproof function 东莞市品超电子有限公司 2019-01-18 CN disclosed
CN-108565480-A A kind of preparation method and product of exotic atom doped graphene/carbon based material with nucleocapsid 中国科学院重庆绿色智能技术研究院 2018-09-21 CN disclosed
US-9121032-B2 Selective ablation of diploid embryos E I DU PONT DE NEMOURS AND COMPANY (US) 2015-09-01 US disclosed
US-20120311736-A1 SELECTIVE ABLATION OF DIPLOID EMBRYOS E.I. du Pont de Nemours and Company and Pioneer Hi-Bred International 2012-12-06 US disclosed
US-8269061-B2 Selective ablation of diploid embryos E.I. du Pont de Nmeours and Company (US) 2012-09-18 US disclosed
US-20120023612-A1 SELECTIVE ABLATION OF DIPLOID EMBRYOS E. I. DU PONT DE NEMOURS AND COMPANY AND PIONEER HI-BRED INTERNATIONAL, INC. (US) 2012-01-26 US disclosed
US-20080216200-A1 Alternative splicing factors polynucleotides, polypeptides and uses thereof PIONEER HI-BRED INTERNATIONAL, INC. 2008-09-04 US disclosed
WO-2005037863-A9 ALTERNATIVE SPLICING FACTORS POLYNUCLEOTIDES, POLYPEPTIDES AND USES THEREOF PIONEER HI BRED INT (US) 2005-06-23 WO disclosed
WO-2005037863-A2 ALTERNATIVE SPLICING FACTORS POLYNUCLEOTIDES, POLYPEPTIDES AND USES THEREOF PIONEER HI-BRED INTERNATIONAL, INC. (US) 2005-04-28 WO disclosed
EP-1406484-A2 ANTI-APOPTOSIS GENES AND METHODS OF USE THEREOF PIONEER HI-BRED INTERNATIONAL, INC. (US) 2004-04-14 EP disclosed
US-20030135889-A1 Methods for enhancing plant transformation frequencies PIONEER HI-BRED INTERNATIONAL, INC. 2003-07-17 US disclosed
EP-1299555-A2 METHODS FOR ENHANCING PLANT TRANSFORMATION FREQUENCIES PIONEER HI-BRED INTERNATIONAL, INC. (US) 2003-04-09 EP disclosed
US-20030056249-A1 Anti-apoptosis genes and methods of use thereof PIONEER HI-BRED INTERNATIONAL, INC. 2003-03-20 US disclosed
US-6512165-B1 Recalcitrant corn; growth stimulation polynucleotide operably linked to a promoter functional in a plant to produce a modified cell; growth stimulant comprises a cell cycle stimulatory polynucleotide or a developmental polynucleotide PIONEER HI-BRED INTERNATIONAL, INC. 2003-01-28 US disclosed
WO-2002101079-A2 ANTI-APOPTOSIS GENES AND METHODS OF USE THEREOF PIONEER HI-BRED INTERNATIONAL, INC. (US) 2002-12-19 WO disclosed
EP-1201661-A1 HETEROAROMATIC RING COMPOUNDS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2002-05-02 EP disclosed
WO-2002004649-A2 METHODS FOR ENHANCING PLANT TRANSFORMATION FREQUENCIES PIONEER HI-BRED INTERNATIONAL, INC. (US) 2002-01-17 WO disclosed